Continuous Venovenous Hemofiltration Without Anticoagulation

ASAIO Journal

Volumn 50, Issue 1, 2004, Pages 76-80

  Uchino, Shigehiko ^b   Fealy, Nigel ^b   Baldwin, Ian ^b   Morimatsu, Hiroshi ^b   Bellomo, Rinaldo ^a  

^a AUSTIN HEALTH   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COAGULATION; DOSIMETERS; PATIENT MONITORING; RISKS;

ANTICOAGULATION;

FILTRATION;

HEPARIN; PROTAMINE; PROTHROMBIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTINUOUS HEMOFILTRATION; CONTROLLED STUDY; CRITICAL ILLNESS; FEMALE; HEMOFILTRATION; HUMAN; INTERMETHOD COMPARISON; INTERNATIONAL STANDARD UNIT; MALE; PROTHROMBIN TIME; RISK ASSESSMENT; SAFETY; TECHNIQUE;

AGED; ANTICOAGULANTS; FEMALE; HEMOFILTRATION; HEPARIN; HEPARIN ANTAGONISTS; HUMANS; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; PLATELET COUNT; PROSPECTIVE STUDIES; PROTAMINES; RENAL REPLACEMENT THERAPY;

EID: 0347320808     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MAT.0000104822.30759.A7     Document Type: Article

References (30)

1. Silvester W, Bellomo R, Cole L: Epidemiology, management, and outcome of severe acute renal failure of critical illness in Australia. Crit Care Med 29: 1910-1915, 2001.
2. Martin PY, Chevrolet JC, Suter P, et al: Anticoagulation in patients treated by continuous venovenous hemofiltration: a retrospective study. Am J Kidney Dis 24: 806-812, 1994.
3. Langley PG, Keays R, Hughes RD, et al: Antithrombin III supplementation reduces heparin requirement and platelet loss during hemodialysis of patients with fulminant hepatic failure. Hepatology 14: 251-256, 1991.
4. Warkentin TE, Kelton JG: Temporal aspects of heparin-induced thrombocytopenia. New Engl J Med 344: 1286-1292, 2001.
5. De Pont AC, Oudemans-van Straaten HM, Roozendaal KJ, et al: Nadroparin versus dalteparin anticoagulation in high-volume, continuous venovenous hemofiltration: A double-blind, randomized, crossover study. Crit Care Med 28: 421-425, 2000.
6. Reeves JH, Cumming AR, Gallagher L, et al: A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration. Crit Care Med 27: 2224-2228, 1999.
7. Tolwani AJ, Campbell RC, Schenk MB, et al: Simplified citrate anticoagulation for continuous renal replacement therapy. Kidney Int 60: 370-374, 2001.
8. Palsson R, Niles JL: Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int 55: 1991-1997, 1999.
9. Fiaccadori E, Maggiore U, Rotelli C, et al: Continuous haemofiltration in acute renal failure with prostacyclin as the sole antihaemostatic agent. Int Care Med 28: 586-593, 2002.
10. Langenecker SA, Felfernig M, Werba A, et al: Anticoagulation with prostacyclin and heparin during continuous venovenous hemofiltration. Crit Care Med 22: 1774-1781, 1994.
11. Vargas Hein O, von Heymann C, Lipps M, et al: Hirudin versus heparin for anticoagulation in continuous renal replacement therapy. Int Care Med 27: 673-679, 2001.
12. Fischer KG, van de Loo A, Bohler J: Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis. Kidney Int 72 (Suppl): S46-50, 1999.
13. Hu ZJ, Iwama H, Suzuki R, et al: Time course of activated coagulation time at various sites during continuous haemodiafiltration using nafamostat mesilate. Int Care Med 25: 524-527, 1999.
14. Ohtake Y, Hirasawa H, Sugai T, et al: Nafamostat mesylate as anticoagulant in continuous hemofiltration and continuous hemodiafiltration. Contrib Nephrol 93: 215-217, 1991.
15. Meier-Kriesche HU, Gitomer J, Finkel K, et al: Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med 29: 748-752, 2001.
16. Tan HK, Baldwin I, Bellomo R: Continuous venovenous hemofiltration without anticoagulation in high-risk patients. Int Care Med 26: 1652-1657, 2000.
17. Bellomo R, Teede H, Boyce N: Anticoagulant regimens in acute continuous hemodiafiltration: a comparative study. Int Care Med 19: 329-332, 1993.
18. Holt AW, Bierer P, Glover P, Plummer JL, et al: Conventional coagulation and thromboelastograph parameters and longevity of continuous renal replacement circuits. Int Care Med 28: 1649-1655, 2002.
19. Knaus WA, EA Draper, DP Wagner, JE Zimmerman: APACHE II: a severity of disease classification system. Crit Care Med 13: 818-829, 1985.
20. Le Gall J-R, Lemeshow S, Saulnier F: A new simplified acute physiology score (SAPS II) based on an European/North American multicenter study. JAMA 270: 2957-2963, 1993.
21. Gabutti L, Marone C, Colucci G, et al: Citrate anticoagulation in continuous venovenous hemodiafiltration: a metabolic challenge. Int Care Med 28: 1419-1425, 2002.
22. Ward DM, Mehta RL: Extracorporeal management of acute renal failure patients at high risk of bleeding. Kidney Int 41 (Suppl): S237-244, 1993.
23. Kaplan AA, Longnecker RE, Folkert VW: Continuous arteriovenous hemofiltration. A report of six months' experience. Ann Intern Med 100: 358-367, 1984.
24. Gretz N, Quintel M, Ragaller M, et al: Low-dose heparinization for anticoagulation in intensive care patients on continuous hemofiltration. Contrib Nephrol 116: 130-135, 1995.
25. van de Wetering J, Westendorp RG, van der Hoeven JG, et al: Heparin use in continuous renal replacement procedures: the struggle between circuit coagulation and patient hemorrhage. J Am Soc Nephrol 7: 145-150, 1996.
26. Davenport A: The coagulation system in the critically ill patients with acute renal failure and the effect of an extracorporeal circuit. Am J Kidney Dis 30 (Suppl 4): 20-27, 1997.
27. Jahansouz F, Lamott J, Shephanson LG, et al: Pharmacy cost analysis of citrate anticoagulation (CIT) for continuous renal replacement therapy (CRRT) (Abstract). J Am Soc Nephrol 12: 171A, 2001.
28. Kitamura N, Hirasawa H, Sugai T, et al: Experience of using APF-06W (PAN-DX) during continuous hemodiafiltration. ICU and CCU 18: 197-202, 1994.
29. Schetz M: Anticoagulation in continuous renal replacement therapy. Contrib Nephrol 132: 283-303, 2001.
30. Gretz N, Quintel M, Ragaller M, et al: Low-dose heparinization for anticoagulation in intensive care patients on continuous hemofiltration. Contrib Nephrol 116: 130-135, 1995.